Rehydration of moderately dehydrated children with transient glucose intolerance using rice oral rehydration solution.
Following the successful rehydration of two moderately dehydrated patients with transient glucose intolerance (TGI) using rice-oral rehydration solution (R-ORS), R-ORS has been used in Hacettepe University Ihsan Dogramaci Children's Hospital Diarrhea Training and Treatment Unit (DTTU) to rehydrate moderately dehydrated children with TGI. The files of children with moderate dehydration and glucose intolerance admitted to the unit were reviewed retrospectively within two periods according to the availability of R-ORS. The clinical and laboratory findings were analysed where available. Before R-ORS became available (September 1993) 6 patients were admitted, all of whom deteriorated with glucose (G)-ORS treatment in 7.0 +/- 3.8 h and were hospitalized for i.v. fluid treatment. During the second period 22 moderately dehydrated children with TGI were admitted. The clinical and laboratory characteristics on admission of the children in the two periods were not statistically different (p > 0.05). Among the 22 patients admitted during the second period 10 were administered G-ORS in the unit and 12 had already received G-ORS at home. Clinical and laboratory deterioration was observed in these 10 patients while receiving G-ORS in the unit within 6.3 +/- 3.7 h and rehydration was continued with R-ORS. Clinical and laboratory improvement were demonstrated in 8 patients within 18.2 +/- 6.5 h. Overall, 17 patients were rehydrated successfully with R-ORS, with a mean time of 18.0 +/- 7.2 h. Five patients were hospitalized. The overall success rate of R-ORS was 77.3%. R-ORS may be considered as an alternative mode of therapy to i.v. treatment in the rehydration of moderately dehydrated children with TGI.
Yurdakök
K
K
Institute of Child Health, Ihsan Dogramaci Children's Hospital Diarrhea Training and Treatment Unit, Hacettepe University, Ankara, Turkey.
Ozmert
E
E
Yalçin
S S
SS
Coşkun
T
T
D003681:Dehydration / Q000150:complications* / Q000628:therapy; D005440:Fluid Therapy; D018149:Glucose Intolerance / Q000150:complications*; D006801:Humans; D007223:Infant; D012275:Oryza; D015532:Rehydration Solutions; D012189:Retrospective Studies; D016896:Treatment Outcome
D015532:Rehydration Solutions